Hemorrhoids Treatment Market Research Report – Global Forecast till 2027

Global Hemorrhoids Treatment market research report, by Treatment type (drugs, non-surgical procedures, surgical procedures), Route of administration (oral, topical agents) Distribution channel (retail pharmacies) – Forecast till 2027

ID: MRFR/Pharma/5534-HCR | February 2021 | Region: Global | 90 pages

Market Scenario:


The Global Hemorrhoids Treatment Market is expected to register a CAGR of ~5.5 % during the forecast period of 2018 to 2023.One of the most uncomfortable disorders a patient can have is hemorrhoids and most of the population under the age of fifty don’t know what hemorrhoids are.  The general population avoids the disorder until they suffer from the disorder and start to feel the symptoms such as pain and itching associated with the condition.  According to the American Society of Colon & Rectal Surgeons, hemorrhoids are one of the most common disorders and more than half the population will develop hemorrhoids after the age of 30.  The prevalence of hemorrhoids (also called piles) in the United States is reported to be 4.4% with most suffering occurring between the ages of 45 and 65, equally in men and women. But only one third of these individuals seek medical treatment such as surgery, medication etc., with most opting for over-the-counter relief purchased from the pharmacies. 


There are two types of haemorrhoids (piles), internal and external, which differ to their location. While there is no exact cause of hemorrhoids, there variety of reasons that can subsidize to the disorder: aging, chronic constipation or diarrhea, pregnancy, heredity, straining during bowel movements, faulty bowel function. Some patients may not even experience symptoms but those that do may notice bleeding during bowel movements, protrusion during bowel movements and itching, pain, and sensitive lumps in the anal area. A variety of options exist for home treatment such as sitz baths, wipes, suppositories, creams, fiber supplements, and hemorrhoid pillows.  Over half of patients purchasing hemorrhoid treatment use a cream.  Preparation H and Tucks are the leading providers of creams, wipes/pads, and suppositories and can be purchased at most grocery and drug stores.


Segmentation:


The Global Hemorrhoids Treatment Market is segmented based on treatment type, route of administration, distribution channel, and region.On the basis of treatment type, the market is segmented into drugs (further sub segmented into laxatives, NSAIDs, and herbals) non-surgical procedures (further sub segmented into band litigation, sclerotherapy, cryotherapy) surgical procedures. Further, on the basis of route of administration the market is segmented into oral, topical agents. Distribution channel is segmented into retail pharmacies, hospital pharmacies, online pharmacies and others.


 Regional Market Summary:


In the current scope of the study, the above-mentioned segments are covered into four global regions, namely- the Americas, Europe, Asia Pacific and the Middle East & Africa. More than half the population in the U.S. will be affected by hemorrhoids in their lives. Hemorrhoids are swollen, inflamed veins in the anal canal and can cause strong irritation in the form of pain and itching. Currently, patients suffering from hemorrhoids who seek relief from their discomfort can choose from an assortment of products with varying positives and negatives. Direct products such as creams, wipes, suppositories and pads are effective at providing temporary relief, but cannot be used for permanent treatment. Hemorrhoid cushions can be used as much as needed but are conspicuous and can be uncomfortable with prolonged use.Moreover, According to Home Care Magazine, in 2014, 24 million baby boomers had reached age 50. Those over age 65 will continue to represent a larger share of the overall population. By 2020, more than 54 million people in the United States will be over age 65. Furthermore, by 2030, members of the 66 to 84 age brackets will constitute an estimated 20 percent of the U.S. population.


 Europe accounted for the second largest market behind Americas. Europe consist of two regions namely Western Europe and Eastern Europe. Western Europe holds the major share of the market, which is majorly contributed by Germany, the U.K., and France. The major factors accountable for the growth of the hemorrhoids treatment market comprise of sedentary lifestyle, lack of physical exercise, alcoholism, obesity, poor fiber intake in diet etc. in most of the regions in Europe. Lack of awareness and preparedness for medical treatment due to a feeling of embarrassment hinders the growth of the market.Asia Pacific is the fastest growing region in hemorrhoids market. Increasing need for better diagnostic devices, better and safe therapeutic approach, rapidly improving technology, and the presence of huge patient pool drive the growth of this market in Asia Pacific region.


Global Hemorrhoids Treatment Market Share (%), by Region, 2017


Sources: Centers for Disease Control and Prevention, U.S. Census Bureau, Kodiak Island Borough School District Annual Reports, Press Release, White Paper, And Company Presentation


Key players:


Some of the key players in the Global Hemorrhoids Treatment Market are Abbott Laboratories, AstraZeneca plc, Bayer AG, Boehringer Ingelheim GmbH, Boston Scientific Corporation, CONMED Corporation, Cook Medical, GlaxoSmithKline, Olympus Corporation, Pfizer Inc., Takeda Pharmaceutical Company, Taro pharmaceuticals Inc., Teva Pharmaceutical Industries Ltd, Astra Zeneca, Glenmark Pharmaceuticals and others


Research Methodology


Market Research Future research is conducted by industry experts who offer insights into industry structure, market segmentation, assessment, Competitive Landscape (CL), penetration, as well as on emerging trends. Besides primary interviews (~ 80%) and secondary research (~ 20%), their analysis is based on their years of professional expertise in respective industries. Our analysts also predict where the market will be headed in the next five to ten years, by analysing historical trends and current market positions. Furthermore, the varying trends of segments and categories geographically presented are studied and are estimated based on the primary and secondary research.



  •  Primary Research


 

Extensive primary research was conducted to gain a deeper insight of the market and the industry performance. In this particular report we have conducted primary surveys (interviews) with key level executives (VPs, CEOs, Marketing Directors, Business Development Managers, and many more) of major players who are active in the market. In addition to analyzing the current and historical trends, our analysts predict where the market is headed, over the next five to ten years.

 


  • Secondary Research


 

Secondary research was mainly used to collect and identify information useful for extensive, technical, market-oriented, and commercial study of the Hemorrhoids Treatment market. It was also used to obtain key information about major players, market classification, and segmentation according to industry trends, geographical markets, and developments related to the market and perspectives. For this study, analysts have gathered information from various credible sources, such as annual reports, SEC filings, journals, white papers, corporate presentations, company web sites, international organization of chemical manufacturers, some paid databases, and many others.

 Intended Audience:



  • Pharmaceutical companies

  • Government and private laboratories

  • Research and Development (R&D) companies

  • Medical research laboratories

  • Market research and consulting service providers


Market Segmentation and Key Market Players


Global Hemorrhoids Treatment Market, by Treatment Type:



  • Drugs

  • Non-surgical procedures

  • Surgical procedures


Global Hemorrhoids Treatment Market, by Route of Administration:



  • Oral

  • Topical Agents


Global Hemorrhoids Treatment Market, by Distribution Channel:



  • Retail pharmacies

  • Hospital pharmacies

  • Online pharmacies

  • Others


Global Hemorrhoids Treatment Market, by Key Players:



  • Abbott Laboratories

  • AstraZeneca plc

  • Bayer AG

  • Boehringer Ingelheim GmbH

  • Boston Scientific Corporation

  • CONMED Corporation

  • Cook Medical

  • GlaxoSmithKline

  • Olympus Corporation

  • Pfizer Inc.

  • Takeda Pharmaceutical Company

  • Taro pharmaceuticals Inc.

  • Teva Pharmaceutical Industries Ltd

  • Astra Zeneca

  • Glenmark Pharmaceuticals


 


 



Report Scope:
Report Attribute/Metric Details
  Market Size   Significant Value
  CAGR   2018-2023: ~5.5 %
  Base Year   2019
  Forecast Period   2027
  Historical Data   2018
  Forecast Units   Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Treatment type, Route of administration, Distribution channel
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   Abbott Laboratories, AstraZeneca plc, Bayer AG, Boehringer Ingelheim GmbH, Boston Scientific Corporation, CONMED Corporation, Cook Medical, GlaxoSmithKline, Olympus Corporation, Pfizer Inc., Takeda Pharmaceutical Company, Taro pharmaceuticals Inc., Teva Pharmaceutical Industries Ltd, Astra Zeneca, Glenmark Pharmaceuticals
  Key Market Opportunities   Medical treatment such as surgery, medication etc.
  Key Market Drivers   Rapidly improving technology, and the presence of huge patient pool drive the growth of this market in Asia Pacific Region


Table of Contents:

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

Chapter 5. Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

Chapter 6. Global Hemorrhoids Treatment Market, by Treatment Type

6.1 Introduction

6.2 Drugs

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

6.2.1 laxatives

6.2.2 NSAIDs

6.2.3 herbals

6.2.4 Others

6.3 Non-Surgical Procedures

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

6.3.1 Band Litigation

6.3.2 Sclerotherapy

6.3.3 Cryotherapy

6.4 Surgical Procedures

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

Chapter 7. Global Hemorrhoids Treatment Market, by Route of administration

7.1 Introduction

7.2 Oral

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

7.3 Topical

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

Chapter 8. Global Hemorrhoids Treatment Market, by Distribution Channel

8.1 Introduction

8.2 Retail Pharmacies

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

8.3 Hospital Pharmacies

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

8.4 Online Pharmacies

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

Chapter 9. Global Hemorrhoids Treatment Market, by Region

9.1 Introduction

9.2 Americas

9.2.1 North America

9.2.1.1 U.S.

9.2.1.2 Canada

9.2.2 South America

9.3 Europe

9.3.1 Western Europe

9.3.1.1 Germany

9.3.1.2 France

9.3.1.3 Italy

9.3.1.4 Spain

9.3.1.5 UK

9.3.1.6 Rest of Western Europe

9.3.2 Eastern Europe

9.4 Asia-Pacific

9.4.1 Japan

9.4.2 China

9.4.3 India

9.4.4 Australia

9.4.5 South Korea

9.4.6 Rest of Asia-Pacific

9.5 Middle East & Africa

9.5.1 Middle East

9.5.2 Africa

Chapter 10. Company Landscape

10.1 Introduction

10.2 Market Share Analysis

10.3 Key Development & Strategies

Chapter 11. Company Profiles

11.1 Abbott Laboratories

11.1.1 Company Overview

11.1.2 Product Overview

11.1.3 Financials Overview

11.1.4 Key Developments

11.1.5 SWOT Analysis

11.2 AstraZeneca plc

11.2.1 Company Overview

11.2.2 Product Overview

11.2.3 Financial Overview

11.2.4 Key Developments

11.2.5 SWOT Analysis

11.3 Bayer AG.

11.3.1 Company Overview

11.3.2 Product Overview

11.3.3 Financial Overview

11.3.4 Key Development

11.3.5 SWOT Analysis

11.4 Boehringer Ingelheim GmbH

11.4.1 Company Overview

11.4.2 Technologys/Business Segment Overview

11.4.3 Financial Overview

11.4.4 Key Development

11.4.5 SWOT Analysis

11.5 Boston Scientific Corporation

11.5.1 Company Overview

11.5.2 Product Overview

11.5.3 Financial overview

11.5.4 Key Developments

11.5.5 SWOT Analysis

11.6 CONMED Corporation

11.6.1 Company Overview

11.6.2 Product Overview

11.6.3 Financial Overview

11.6.4 Key Developments

11.6.5 SWOT Analysis

11.7 Cook Medical

11.7.1 Overview

11.7.2 Product Overview

11.7.3 Financial Overview

11.7.4 Key Developments

11.7.5 SWOT Analysis

11.8 GlaxoSmithKline

11.8.1 Overview

11.8.2 Product/ Technology Overview

11.8.3 Financials

11.8.4 Key Developments

11.8.5 SWOT Analysis

11.9 Olympus Corporation.

11.9.1 Overview

11.9.2 Product Overview

11.9.3 Financials

11.9.4 Key Developments

11.9.5 SWOT Analysis

11.10 Pfizer Inc

11.10.1 Overview

11.10.2 Product Overview

11.10.3 Financials

11.10.4 Key Developments

11.10.5 SWOT Analysis

11.11 Takeda Pharmaceutical Company

11.11.1 Overview

11.11.2 Product Overview

11.11.3 Financials

11.11.4 Key Developments

11.11.5 SWOT Analysis

11.12 Others

Chapter 12 MRFR Conclusion

12.1 Key Findings

12.1.1 From CEO’s Viewpoint

12.1.2 Unmet Needs of the Market

12.2 Key Companies to Watch

12.3 Predictions for the Hemorrhoids Treatment Market Industry

Chapter 13. Appendix

LIST OF TABLES

Table 1 Global Hemorrhoids Treatment Market Synopsis, 2020–2027

Table 2 Global Hemorrhoids Treatment Market Estimates and Forecast, 2020–2027 (USD Million)

Table 3 Global Hemorrhoids Treatment Market, by Region, 2020–2027 (USD Million)

Table 4 Global Hemorrhoids Treatment Market, by Treatment Type, 2020–2027 (USD Million)

Table 5 Global Hemorrhoids Treatment Market, by Route of administration, 2020–2027 (USD Million)

Table 6 Global Hemorrhoids Treatment Market, by Distribution Channel, 2020–2027 (USD Million)

Table 7 North America: Hemorrhoids Treatment Market , by Treatment Type, 2020–2027 (USD Million)

Table 8 North America: Hemorrhoids Treatment Market , by Route of administration, 2020–2027 (USD Million)

Table 9 North America: Hemorrhoids Treatment Market , by Distribution Channel, 2020–2027 (USD Million)

Table 10 US: Hemorrhoids Treatment Market , by Treatment Type, 2020–2027 (USD Million)

Table 11 US: Hemorrhoids Treatment Market , by Route of administration, 2020–2027 (USD Million)

Table 12 US: Hemorrhoids Treatment Market , by Distribution Channel, 2020–2027 (USD Million)

Table 13 Canada: Hemorrhoids Treatment Market ,by Treatment Type, 2020–2027 (USD Million)

Table 14 Canada: Hemorrhoids Treatment Market , by Route of administration, 2020–2027 (USD Million)

Table 15 Canada: Hemorrhoids Treatment Market , by Distribution Channel, 2020–2027 (USD Million)

Table 16 South America: Hemorrhoids Treatment Market , by Treatment Type, 2020–2027 (USD Million)

Table 17 South America: Hemorrhoids Treatment Market , by Route of administration, 2020–2027 (USD Million)

Table 18 South America: Hemorrhoids Treatment Market , by Distribution Channel, 2020–2027 (USD Million)

Table 19 Europe: Hemorrhoids Treatment Market , by Treatment Type, 2020–2027 (USD Million)

Table 20 Europe: Hemorrhoids Treatment Market , by Route of administration, 2020–2027 (USD Million)

Table 21 Europe: Hemorrhoids Treatment Market , by Distribution Channel, 2020–2027 (USD Million)

Table 22 Western Europe: Hemorrhoids Treatment Market , by Treatment Type, 2020–2027 (USD Million)

Table 23 Western Europe: Hemorrhoids Treatment Market , by Route of administration, 2020–2027 (USD Million)

Table 24 Western Europe: Hemorrhoids Treatment Market , by Distribution Channel, 2020–2027 (USD Million)

Table 25 Eastern Europe: Hemorrhoids Treatment Market , by Treatment Type, 2020–2027 (USD Million)

Table 26 Eastern Europe: Hemorrhoids Treatment Market , by Route of administration, 2020–2027 (USD Million)

Table 27 Eastern Europe: Hemorrhoids Treatment Market , by Distribution Channel, 2020–2027 (USD Million)

Table 28 Asia-Pacific: Hemorrhoids Treatment Market , by Treatment Type, 2020–2027 (USD Million)

Table 29 Asia-Pacific: Hemorrhoids Treatment Market , by Route of administration, 2020–2027 (USD Million)

Table 30 Asia-Pacific: Hemorrhoids Treatment Market , by Distribution Channel, 2020–2027 (USD Million)

Table 31 Middle East & Africa: Hemorrhoids Treatment Market , by Treatment Type, 2020–2027 (USD Million)

Table 32 Middle East & Africa: Hemorrhoids Treatment Market , by Route of administration, 2020–2027 (USD Million)

Table 33 Middle East & Africa: Hemorrhoids Treatment Market , by Distribution Channel, 2020–2027 (USD Million)

LIST OF FIGURES

Figure 1 Research Process

Figure 2 Global Hemorrhoids Treatment Market

Figure 3 Market Dynamics for Global Hemorrhoids Treatment Market

Figure 4 Global Hemorrhoids Treatment Market Share, by Treatment Type, 2020

Figure 5 Global Hemorrhoids Treatment Market Share, by Route of administration, 2020

Figure 6 Global Hemorrhoids Treatment Market Share, by Distribution Channel, 2020

Figure 7 Global Hemorrhoids Treatment Market Share, by Region, 2020

Figure 8 North America: Hemorrhoids Treatment Market Share, by Country, 2020

Figure 9 Europe: Hemorrhoids Treatment MarketShare, by Country, 2020

Figure 10 Asia-Pacific: Hemorrhoids Treatment Market Share, by Country, 2020

Figure 11 Middle East & Africa: Hemorrhoids Treatment Market Share, by Region, 2020

Figure 12 Global Hemorrhoids Treatment Market: Company Share Analysis, 2020 (%)

Figure 13 Abbott Laboratories Company: Key Financials

Figure 14 Abbott Laboratories Company: Segmental Revenue

Figure 15 Abbott Laboratories Company Geographical Revenue

Figure 16 AstraZeneca plc Melsungen Ag.: Key Financials

Figure 17 AstraZeneca plc Melsungen Ag Segmental Revenue

Figure 18 AstraZeneca plc Melsungen Ag: Geographical Revenue

Figure 19 Bayer AG: Key Financials

Figure 20 Bayer AG: Segmental Revenue

Figure 21 Bayer AG: Geographical Revenue

Figure 22 Boehringer Ingelheim GmbH: Key Financials

Figure 23 Boehringer Ingelheim GmbH: Segmental Revenue

Figure 24 Boehringer Ingelheim GmbH: Geographical Revenue

Figure 25 Boston Scientific Corporation Products: Key Financials

Figure 26 Boston Scientific Corporation Products: Segmental Revenue

Figure 27 Boston Scientific Corporation Products: Geographical Revenue